<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00661648</url>
  </required_header>
  <id_info>
    <org_study_id>TGC-AP-03</org_study_id>
    <secondary_id>Kochi University</secondary_id>
    <nct_id>NCT00661648</nct_id>
  </id_info>
  <brief_title>Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection</brief_title>
  <official_title>Prevention for Surgical Site Infection After Pancreatic Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kochi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kochi University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluated that strict control of perioperative blood glucose following pancreatic
      resection by using an artificial pancreas would improve postoperative surgical site
      infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study recruited 50 patients undergoing elective pancreatic resection for pancreatic
      diseases. Perioperative blood glucose concentration was continuously monitored using an
      artificial pancreas system. We prospectively divided into two groups: one for whom glucose
      levels were controlled using a manual injection of insulin according to the commonly used
      sliding scale and another that received programmed infusion of insulin determined by the
      control algorithm of the artificial pancreas.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2007</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <primary_completion_date type="Anticipated">April 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the incidence of surgical site infection</measure>
    <time_frame>30th postoperative day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence of hypoglycemia and cost during the hospitalization</measure>
    <time_frame>during the hospitalization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pancreatic Diseases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>glucose levels were controlled using sliding scale</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>received programmed infusions of insulin determined by the control algorithm of the artificial pancreas</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>the closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan)</intervention_name>
    <description>artificial pancreas</description>
    <arm_group_label>2</arm_group_label>
    <other_name>an artificial pancreas system (Nikkiso Inc, Tokyo, Japan)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing elective pancreatic resection for pancreatic diseases.

        Exclusion Criteria:

          -  weight loss greater than 10% during the previous 6 months

          -  sign of distant metastasis

          -  respiratory, renal, or heart disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Takehiro Okabayashi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kochi Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Takehiro Okabayashi, MD</last_name>
    <phone>81-88-880-2370</phone>
    <email>tokabaya@kochi-u.ac.jp</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kazuhiro Hanazaki, Prof</last_name>
    <phone>81-88-880-2370</phone>
    <email>im31@kochi-u.ac.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kochi Medical School</name>
      <address>
        <city>Nankoku-City</city>
        <state>Kochi</state>
        <zip>783-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takehiro Okabayashi, MD</last_name>
      <phone>81-88-880-2370</phone>
      <email>tokabaya@kochi-u.ac.jp</email>
    </contact>
    <contact_backup>
      <last_name>Kazuhiro Hanazaki, Prof</last_name>
      <phone>81-88-880-2370</phone>
      <email>im31@kochi-u.ac.jp</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2008</study_first_submitted>
  <study_first_submitted_qc>April 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2008</study_first_posted>
  <last_update_submitted>January 28, 2009</last_update_submitted>
  <last_update_submitted_qc>January 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kochi University</name_title>
    <organization>Kochi Medical School</organization>
  </responsible_party>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
    <mesh_term>Pancreatin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 19, 2009</submitted>
    <returned>July 9, 2009</returned>
    <submitted>July 13, 2009</submitted>
    <returned>August 19, 2009</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

